AATS from April 29 – May 1, 2018 in San Diego, CA
BioStable Science & Engineering will be at the 98th AATS Annual Meeting from April 28 – May 1, 2018 in San Diego, CA.
STS from January 27-31, 2018 in Florida
BioStable Science & Engineering will be at the 54th STS Annual Meeting of the Society of Thoracic Surgeons from January 27 – 31, 2018 in Ft. Lauderdale, FL at booth 214.
EACTS from October 7 – 11, 2017 in Vienna Austria
BioStable Science & Engineering will be at the 31st EACTS Annual Meeting of European Association for Cardio-Thoracic Surgery from October 7-11, 2017 in Vienna, Austria.
HAART 200 First Commercial Use
BioStable Science & Engineering, Inc. announced today the first commercial use of the HAART 200 Aortic Annuloplasty Device in the U.S. by doctors at the West Virginia University (WVU) Heart and Vascular Institute in Morgantown, West Virginia. Drs. Lawrence Wei, Vinay Badhwar and J. Scott Rankin were the collaborating surgeons for the procedure.
HAART 200 Receives FDA Clearance
BioStable Science & Engineering, Inc. announced today it has received FDA market clearance for the HAART 200 Aortic Annuloplasty Device, the first and only annuloplasty device designed specifically for bicuspid aortic valve repair.